Literature DB >> 11354912

Ultrastructure of Achilles tendon from rats after treatment with fleroxacin.

M Shakibaei1, R Stahlmann.   

Abstract

Quinolone therapy can be associated with tendon disorders (tendinitis, ruptures), but little is known about possible ultrastructural changes in tendons after exposure to these antimicrobials. We studied the Achilles tendons from fleroxacin-treated adult rats by electron microscopy. Wistar rats were treated orally with single oral doses of 0, 30, 100, 300 or 600 mg fleroxacin/kg body weight (n = 6 per group). The animals were killed 4 weeks after treatment. Achilles tendon samples were collected and tangential sections were made from the distal part of the tendon. Subsequently, tendons were cut crosswise for preparation of ultrathin sections. Samples were fixed by using glutaraldehyde, osmium tetroxide, tannic acid and finally contrasted with uranyl acetate/lead citrate before they were examined by transmission electron microscopy. The rats did not show any general effects such as behavioural changes or body weight changes which could be attributed to the treatment. However, we were able to detect pathological changes even at the lowest dose level (30 mg/kg), which increased in incidence and severity with increasing doses. Tenocytes exhibited degenerative changes such as multiple vacuoles and large vesicles in the cytoplasm that resulted from swelling and dilatation of cell organelles (mitochondria, endoplasmic reticulum). The nucleus became dense and the chromatin had clumped to form rough plaques. The cells detached from the extracellular matrix. Other important findings were a general decrease of the fibril diameter and an increase in the distance between the collagenous fibrils. The finding that these rather low single dose of a fluoroquinolone induce ultrastructural changes in Achilles tendons from rats, which were not associated with clinical symptoms and which were still present 4 weeks after treatment, is of concern. Further toxicological as well as clinical studies are needed to characterize the conditions under which quinolone-induced tendon lesions develop.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11354912     DOI: 10.1007/s002040000203

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  13 in total

1.  Evidence of tendinitis provoked by fluoroquinolone treatment: a case-control study.

Authors:  Giovanni Corrao; Antonella Zambon; Lorenza Bertù; Anna Mauri; Valentina Paleari; Camillo Rossi; Mauro Venegoni
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

2.  [Bilateral Achilles tendinitis as adverse reaction to levofloxacine. Concerning a case].

Authors:  E Vila; A Anguita; M Borrell
Journal:  Aten Primaria       Date:  2003       Impact factor: 1.137

Review 3.  Safety considerations of fluoroquinolones in the elderly: an update.

Authors:  Ralf Stahlmann; Hartmut Lode
Journal:  Drugs Aging       Date:  2010-03-01       Impact factor: 3.923

Review 4.  Fluoroquinolones in the elderly: safety considerations.

Authors:  Ralf Stahlmann; Hartmut Lode
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

5.  The effects of enrofloxacin on canine tendon cells and chondrocytes proliferation in vitro.

Authors:  S Lim; M A Hossain; J Park; S H Choi; G Kim
Journal:  Vet Res Commun       Date:  2007-11-20       Impact factor: 2.459

6.  Effect of Ciprofloxacin on Susceptibility to Aortic Dissection and Rupture in Mice.

Authors:  Scott A LeMaire; Lin Zhang; Wei Luo; Pingping Ren; Alon R Azares; Yidan Wang; Chen Zhang; Joseph S Coselli; Ying H Shen
Journal:  JAMA Surg       Date:  2018-09-19       Impact factor: 14.766

7.  TOL19-001 reduces inflammation and MMP expression in monolayer cultures of tendon cells.

Authors:  Catherine Baugé; Sylvain Leclercq; Thierry Conrozier; Karim Boumediene
Journal:  BMC Complement Altern Med       Date:  2015-07-09       Impact factor: 3.659

8.  A prospective, observational study of adverse reactions to drug regimen for multi-drug resistant pulmonary tuberculosis in central India.

Authors:  Rohan Hire; A S Kale; G N Dakhale; Nilesh Gaikwad
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-09-01       Impact factor: 2.576

9.  Effect of topical fluoroquinolones on the expression of matrix metalloproteinases in the cornea.

Authors:  Victor E Reviglio; Melinda A Hakim; Jae K Song; Terrence P O'Brien
Journal:  BMC Ophthalmol       Date:  2003-10-06       Impact factor: 2.209

10.  Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study.

Authors:  Nick Daneman; Hong Lu; Donald A Redelmeier
Journal:  BMJ Open       Date:  2015-11-18       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.